Close Menu

NEW YORK – Dutch diagnostics company SkylineDx announced on Tuesday a partnership with the multiple myeloma department of Wuerzburg University Medical Center II in Germany to assess the company's MMprofiler diagnostic test.

The MMprofiler test is a microarray-based, gene-expression test for multiple myeloma based on a 92-gene signature called SKY92 for diagnosing patients in high and standard risk groups.  The test runs on Thermo Fisher Scientific Affymetrix microarrays and is offered as a CE-IVD kit in Europe, and as a laboratory-developed test in the US.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Master's and doctoral students in the UK call on funding groups to extend their grants for the duration of the disruption caused by the COVID-19 outbreak, the Guardian reports.

Squid can make edits to their RNA within the cytoplasm of their axons, Science News reports.

The Chan Zuckerberg Initiative is putting $25 million toward COVID-19 treatment research, according to the Verge.

In Science this week: researchers engineer version of Cas9 that is nearly PAM-less, and more.

May
06
Sponsored by
Isoplexis

This webinar will discuss the application of single-cell proteomics and immune-imaging in adoptive cell therapy (ACT) for cancer.